Multivalent DLL3 antibodies
US9334318B1 · kind B1 · utility
8Cited by
47References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 11, 2016 |
| Grant date | May 10, 2016 |
| Priority date | — |
| Expiry date | Jan 11, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/70596
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.